NCT01898078View on ClinicalTrials.gov

Food Effect Study of Alisertib (MLN8237) in Participants With Advanced Solid Tumors or Lymphomas

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

July 16, 2013

Primary Completion Date

March 5, 2014

Study Completion Date

January 24, 2017

Conditions
Advanced Solid TumorsLymphoma
Interventions
DRUG

Alisertib

Alisertib ECT

Trial Locations (3)

Unknown

The Bronx

Nashville

San Antonio

Sponsors
All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY